中国生物制药(01177.HK)与清普生物签署QP001独家合作协议

阿斯达克财经
Mar 06, 2025

中国生物制药(01177.HK) 公布,与南京清普生物就其研发的国家2类新药QP001在中国大陆地区达成独家合作协议。集团预计该产品将于近期获中国国家药品监督管理局批准上市。QP001单次注射即可实现24小时的持续强效镇痛,是中国首款一日一次的长效镇痛NSAID注射液,有望接力氟比洛芬酯注射液(商品名:凯纷)成为集团镇痛领域的下一款重磅产品。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10